Dosage Forms
Form | Route | Strength |
---|---|---|
Capsule | Oral | 250 mg |
Capsule | Oral | 500 mg |
Capsule | 250 mg | |
Capsule, coated | Oral | 250 mg |
Capsule, coated | Oral | 542 mg |
Powder, for suspension | Oral | 2.,5 g |
Powder; syrup | Oral | 62.5 mg/5mL |
Powder, for suspension | Oral | 125 mg |
Powder, for suspension | Oral | 2500 mg |
Powder, for suspension | Oral | 5 g |
Powder, for suspension | Oral | 5.41 g |
Powder, for solution | Oral | 5.7375 g |
Capsule, coated | Oral | 500 mg |
Suspension | Oral | 2.,5 g |
Capsule | Oral | 250 mg/1 |
Capsule | Oral | 500 mg/1 |
Suspension | Oral | 5 g |
Tablet, coated | Oral | 250 mg |
Powder, for suspension | Oral | 62.,5 mg/5mL |
Powder; syrup | Oral | 125 mg/5mL |
Prices
Unit description | Cost | Unit |
---|---|---|
Dicloxacillin Sodium 500 mg capsule | 1.25USD | capsule |
Dicloxacillin 500 mg capsule | 1.2USD | capsule |
Dicloxacillin Sodium 250 mg capsule | 0.,69USD | capsule |
Dicloxacillin 250 mg capsule | 0.66USD | capsule |
DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.
Patents Not Available
Properties
State Solid Experimental Properties
Property | Value | Source |
---|---|---|
water solubility | 3.,63 mg/L | Not Available |
logP | 2.91 | HANSCH,C ET AL. (1995) |
Predicted Properties
Property | Value | Source |
---|---|---|
Water Solubility | 0.0296 mg/mL | ALOGPS |
logP | 3.19 | ALOGPS |
logP | 2.91 | ChemAxon |
logS | -4.,2 | ALOGPS |
pKa (Strongest Acidic) | 3.75 | ChemAxon |
pKa (Strongest Basic) | -0.71 | ChemAxon |
Physiological Charge | -1 | ChemAxon |
Hydrogen Acceptor Count | 5 | ChemAxon |
Hydrogen Donor Count | 2 | ChemAxon |
Polar Surface Area | 112.74 Å2 | ChemAxon |
Rotatable Bond Count | 3 | ChemAxon |
Refractivity | 111.,44 m3 * mol-1 | Chema .on |
polariserbarhed | 42., | ChemAxon |
Rule of Five | Yes | ChemAxon |
Ghose Filter | Yes | ChemAxon |
Veber’s Rule | No | ChemAxon |
MDDR-like Rule | No | ChemAxon |
Predicted ADMET Features
Property | Value | Probability |
---|---|---|
Human Intestinal Absorption | + | 0.,8368 |
Blood Brain Barrier | – | 0.9903 |
Caco-2 permeable | – | 0.8957 |
P-glycoprotein substrate | Non-substrate | 0.6204 |
P-glycoprotein inhibitor I | Non-inhibitor | 0.8951 |
P-glycoprotein inhibitor II | Non-inhibitor | 0.9204 |
Renal organic cation transporter | Non-inhibitor | 0.9629 |
CYP450 2C9 substrate | Non-substrate | 0.,8262 |
CYP450 2D6 substrate | Non-substrate | 0.905 |
CYP450 3A4 substrate | Substrate | 0.5977 |
CYP450 1A2 substrate | Inhibitor | 0.8592 |
CYP450 2C9 inhibitor | Non-inhibitor | 0.891 |
CYP450 2D6 inhibitor | Non-inhibitor | 0.918 |
CYP450 2C19 inhibitor | Non-inhibitor | 0.8832 |
CYP450 3A4 inhibitor | Non-inhibitor | 0.,819 |
CYP450 inhibitory promiscuity | Low CYP Inhibitory Promiscuity | 0.9186 |
Ames test | Non AMES toxic | 0.6979 |
Carcinogenicity | Carcinogens | 0.5672 |
Biodegradation | Not ready biodegradable | 1.0 |
Rat acute toxicity | 1.9946 LD50, mol/kg | Not applicable |
hERG inhibition (predictor I) | Weak inhibitor | 0.,9996 |
hERG inhibition (predictor II) | Non-inhibitor | 0.8486 |
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties.,>
Forudsagt LC-MS/MS
Ikke Tilgængelig
Forudsagt MS/MS Spektrum – 10V, Negative (Kommenteret)
Forudsagt LC-MS/MS
Ikke Tilgængelig
Forudsagt MS/MS Spektrum – 20V, Negative (Kommenteret)
Forudsagt LC-MS/MS
Ikke Tilgængelig
Forudsagt MS/MS Spektrum – 40V, Negative (Kommenteret)
Forudsagt LC-MS/MS
Ikke Tilgængelig
Mål
Slags Protein Organisme Listeria monocytogenes serotype 4, str., LL195 Pharmacological action
Yes
Actions
Inhibitor
General Function Not Available Specific Function Penicillin binding Gene Name pbpC Uniprot ID A0A0E1R3H3 Uniprot Name Penicillin-binding protein 3 Molecular Weight 75015.58 Da
- Gutkind GO, Ogueta SB, de Urtiaga AC, Mollerach ME, de Torres RA: Participation of PBP 3 in the acquisition of dicloxacillin resistance in Listeria monocytogenes. J Antimicrob Chemother. 1990 May;25(5):751-8.,
Kind Protein Organism Streptococcus pneumoniae (strain ATCC BAA-255 / R6) Pharmacological action
Yes
Actions
Inhibitor
General Function Transferase activity, transferring acyl groups Specific Function Not Available Gene Name pbp1b Uniprot ID Q7CRA4 Uniprot Name Penicillin-binding protein 1b Molecular Weight 89479.92 Da
- Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae., Antimicrob Agents Chemother. 1980 Oct;18(4):629-37.
Kind Protein Organism Streptococcus pneumoniae (strain ATCC BAA-255 / R6) Pharmacological action
Yes
Actions
Inhibitor
General Function Transferase activity, transferring acyl groups Specific Function Not Available Gene Name pbp2a Uniprot ID Q8DNB6 Uniprot Name Penicillin-binding protein 2a Molecular Weight 80797.,94 da
- Williamilliamson R, Hakenbeck R, Tomas.A: in vivo interaktion mellem beta-lactam-antibiotika og de penicillinbindende proteiner fra Streptococcus pneumoniae. Antimicrob Agenter Chemother. 1980 okt; 18 (4): 629-37.,
Kind Protein Organism Streptococcus pneumoniae Pharmacological action
Yes
Actions
Inhibitor
General Function Serine-type d-ala-d-ala carboxypeptidase activity Specific Function Not Available Gene Name pbp3 Uniprot ID Q75Y35 Uniprot Name Penicillin-binding protein 3 Molecular Weight 45209.84 Da
- Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother., 1980 Oct;18(4):629-37.
Kind Protein Organism Streptococcus pneumoniae (strain ATCC BAA-255 / R6) Pharmacological action
Yes
Actions
Inhibitor
General Function Penicillin binding Specific Function Cell wall formation. Gene Name pbpA Uniprot ID Q8DR59 Uniprot Name Penicillin-binding protein 1A Molecular Weight 79700.9 Da
- Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae., Antimicrob Agents Chemother. 1980 Oct;18(4):629-37.
Kind Protein Organism Streptococcus pneumoniae (strain ATCC BAA-255 / R6) Pharmacological action
Yes
Actions
Inhibitor
General Function Not Available Specific Function Penicillin binding Gene Name penA Uniprot ID P0A3M6 Uniprot Name Penicillin-binding protein 2B Molecular Weight 73872.,305 Da
- Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37.
Enzymes
Kind Protein Organism Humans Pharmacological action
Unknown
Actions
Inducer
General Function Vitamin d3 25-hydroxylase activity Specific Function Cytochromes P450 are a group of heme-thiolate monooxygenases., I levermikrosomer er dette en .ym involveret i en NADPH-afhængig elektrontransportvej. Det udfører en række o .idation reagere… Gen Navn CYP3A4 Uniprot-ID P08684 Uniprot Navn Cytochrom P450 3A4-Molekylær Vægt 57342.67 Da
- Yasuda K, Ranade En, Venkataramanan R, S Strom, Chupka J, Ekins S, Schuetz E, Bachmann K: En omfattende in vitro og in silico analyse af antibiotika for at aktivere pregnane X receptor og inducerer CYP3A4 i leveren og tarmen. Stof Metab Dispos. 2008 August;36 (8): 1689-97. doi: 10.1124/dmd.108.020701. Epub 2008 27 Maj.,>
Transporters
Binding Properties
×
Property | Measurement | pH | Temperature (°C) | |
---|---|---|---|---|
Ki (nM) | 7200000 | N/A | N/A | 15567297 / 15974593 |
Details
Binding Properties1., Opløst stof carrier familien 15-1
Slags Protein Organisme Mennesker Farmakologiske indsats
Ukendt
Handlinger
– Hæmmer
Generelle Funktion Proton-afhængige oligopeptide sekundær aktiv transmembrane transporter aktivitet Bestemt Funktion Proton-kombineret indtagelse af oligopeptides af 2 til 4 aminosyrer med en præference for dipeptides. Kan udgøre en vigtig vej til absorption af slutprodukter til proteinfordøjelse. Gene navn SLC15A1 Uniprot ID P46059 Uniprot navn opløst carrier familie 15 medlem 1 molekylvægt 78805.,265 Da
- Luckner S, Brandsch M: Samspillet mellem 31 beta-lactam antibiotika med H+/peptid-symporter PEPT2: analyse af affinitet konstanter og sammenligning med PEPT1. Eur J Pharm Biopharm. 2005 Jan;59 (1): 17-24.,
Binding Properties
×
Property | Measurement | pH | Temperature (°C) | |
---|---|---|---|---|
Ki (nM) | 420000 | N/A | N/A | 21741846 |
Details
Binding Properties2., Opløst stof carrier familien 15-2
Slags Protein Organisme Mennesker Farmakologiske indsats
Ukendt
Handlinger
– Hæmmer
Generelle Funktion Peptid:proton-symporter aktivitet Bestemt Funktion Proton-kombineret indtagelse af oligopeptides af 2 til 4 aminosyrer med en præference for dipeptides. Gene navn SLC15A2 Uniprot ID1616348 Uniprot navn opløst carrier familie 15 medlem 2 molekylvægt 81782.,77 Da
- Luckner S, Brandsch M: Samspillet mellem 31 beta-lactam antibiotika med H+/peptid-symporter PEPT2: analyse af affinitet konstanter og sammenligning med PEPT1. Eur J Pharm Biopharm. 2005 Jan;59 (1): 17-24.
x
Forbedre patienternes resultater
Opbygge et effektivt beslutningsstøtte værktøjer med branchens mest omfattende drug-drug interaktion checker.,
læs mere
Drug oprettet den 13 juni 2005 07:24 / Opdateret den 07 januar, 2021 17:57
0